Prognostic models for advanced melanoma patients treated with anti-PD-1 monotherapy.

被引：0
|
作者：
Bai, Xue
Kim, Michelle S.
Kasumova, Gyulnara G.
Cohen, Justine Vanessa
Lawrence, Donald P.
Freedman, Christine
Fadden, Riley
Rubin, Krista M.
Sharova, Tatyana
Flaherty, Keith
Sullivan, Ryan J.
Boland, Genevieve Marie
机构：
[1] MGH, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Surg Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RADIOLOGICAL DYNAMICS AND RESISTANCE TYPES IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH ANTI-PD-1 MONOTHERAPY
    Bai, Xue
    Kim, Michelle
    Kasumova, Gyulnara
    Si, Lu
    Tang, Bixia
    Cui, Chuanliang
    Yang, Xiaoling
    Wei, Xiaoting
    Cohen, Justine
    Lawrence, Donald
    Freedman, Christine
    Fadden, Riley
    Rubin, Krista
    Sharova, Tatyana
    Frederick, Dennie
    Flaherty, Keith
    Sullivan, Ryan
    Guo, Jun
    Boland, Genevieve
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A136 - A137
  • [2] Peritoneum metastasis (PM) as a prognostic factor in metastatic gastric cancer (MGC) treated with anti-PD-1/PD-L1 monotherapy.
    Narita, Yukiya
    Sugiyama, Keiji
    Mitani, Seiichiro
    Honda, Kazunori
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Ura, Takashi
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Demographic characteristics and peripheral blood clinical laboratory variables predict irAE occurrence in patients with advanced melanoma receiving anti-PD-1 monotherapy.
    Bai, Xue
    Kim, Michelle S.
    Kasumova, Gyulnara
    Cohen, Justine
    Lawrence, Donald
    Freedman, Christine
    Fadden, Riley
    Rubin, Krista
    Sharova, Tatyana
    Flaherty, Keith
    Sullivan, Ryan
    Boland, Genevieve
    [J]. CANCER RESEARCH, 2020, 80 (19) : 55 - 55
  • [4] Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy
    Zhou, Jian-Guo
    Liang, Bo
    Liu, Jian-Guo
    Jin, Su-Han
    He, Si-Si
    Frey, Benjamin
    Gu, Ning
    Fietkau, Rainer
    Hecht, Markus
    Ma, Hu
    Gaipl, Udo S.
    [J]. CELLS, 2021, 10 (05)
  • [5] Organ site-specific radiological responses in anti-PD-1 monotherapy treated advanced melanoma patients.
    Bai, Xue
    Kim, Michelle S.
    Kasumova, Gyulnara
    Cohen, Justine Vanessa
    Lawrence, Donald P.
    Freedman, Christine
    Fadden, Riley
    Rubin, Krista M.
    Sharova, Tatyana
    Frederick, Dennie T.
    Flaherty, Keith
    Sullivan, Ryan J.
    Boland, Genevieve Marie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH ANTI-PD-1 THERAPY - THE MELIMMUNE SCORE
    Lobo-Martins, Soraia
    Martins-Branco, Diogo
    Semedo, Patricia Miguel
    Alvim, Cecilia Melo
    Monteiro, Ana Maria
    Vendrell, Ines
    Gouveia, Emanuel
    Passos, Maria Jose
    Costa, Luis
    Mansinho, Andre
    de Sousa, Rita Teixeira
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A4 - A4
  • [7] Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy.
    Da Silva, Ines Pires
    Ahmed, Tasnia
    Lo, Serigne
    Reijers, Irene L. M.
    Weppler, Alison
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Lebbe, Celeste
    Mangana, Joanna
    Nguyen, Khang
    Zimmer, Lisa
    Ascierto, Paolo Antonio
    Stout, Dan
    Lyle, Megan
    Klein, Oliver
    Gerard, Camille Lea
    Blank, Christian U.
    Menzies, Alexander M.
    Long, Georgina V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Second primary melanoma in advanced melanoma patients treated with anti-PD-1 monoclonal antibodies.
    Funck-Brentano, Elisa
    Charvet, Estelle
    Chaplain, Louise
    Gantzer, Amelie
    Kassem, Oula
    Longvert, Christine
    Blom, Astrid
    Dupin, Nicolas
    Aractingi, Selim
    Hamon, Maxime
    Zimmermann, Ute
    Emile, Jean-Francois
    Sohier, Pierre
    Kramkimel, Nora
    Saiag, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy
    Funck-Brentano, Elisa
    Baghad, Bouchra
    Fort, Magali
    Aouidad, Iman
    Roger, Anissa
    Beauchet, Alain
    Otmezguine, Yves
    Blom, Astrid
    Longvert, Christine
    Boru, Blandine
    Saiag, Philippe
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (06) : 1707 - 1714
  • [10] Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice
    van Zeijl, Michiel C. T.
    van den Eertwegh, Alfons J. M.
    Wouters, Michel W. J. M.
    de Wreede, Liesbeth C.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan-Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    van Der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    van Der Hoeven, Jacobus J. M.
    Haanen, John B. A. G.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 317 - 326
12345